Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
567-581
Author(s):
Fabrizio Manetti and Maurizio Botta
Cancer Chemoprevention Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
45-54
Author(s):
K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone
Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma
Journal:
Current Drug Targets
Volume:
3
Page:
369-378
Author(s):
Ee-Tsin Wong, Yat-Peng Chew, Linda A. Lee and Caroline G.L. Lee
Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1781-1807
Author(s):
I. Virgolini, T. Traub, C. Novotny, M. Leimer, B. Fuger, S. R. Li, P. Patri, T. Pangerl, P. Angelberger, M. Raderer, G. Burggasser, F. Andreae, A. Kurtaran and R. Dudczak
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs